Health · 3 views
FDA again bypasses advisers to remove black-box warnings from menopause treatments
Some experts express concern about ‘lack of transparency’ as agency removes warnings on three estrogen patches Three more patches for treating menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer…
Summary
Some experts express concern about ‘lack of transparency’ as agency removes warnings on three estrogen patches Three more patches for treating menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer and dementia, officials at the US Food and Drug Administration (FDA) said on Friday.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- How mental health and cancer survivorship intersectContinue reading
- New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapiesContinue reading
- Platelets may play an unexpected role in glioblastoma progressionContinue reading
- Medline electric beds pose fire hazard after 2 deaths, FDA warnsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow